Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SOPHiA GENETICS (SOPH) Non-Current Deffered Revenue (2020 - 2021)

Historic Non-Current Deffered Revenue for SOPHiA GENETICS (SOPH) over the last 2 years, with Q3 2021 value amounting to $134000.0.

  • SOPHiA GENETICS's Non-Current Deffered Revenue changed N/A to $134000.0 in Q3 2021 from the same period last year, while for Sep 2021 it was $134000.0, marking a year-over-year change of. This contributed to the annual value of $142000.0 for FY2020, which is N/A changed from last year.
  • Per SOPHiA GENETICS's latest filing, its Non-Current Deffered Revenue stood at $134000.0 for Q3 2021.
  • SOPHiA GENETICS's 5-year Non-Current Deffered Revenue high stood at $142000.0 for Q4 2020, and its period low was $134000.0 during Q3 2021.